Trial NCT02833701

View at ClinicalTrials.gov 
Org. Study IDs: 0769-15-FB
Secondary IDs: NCI-2016-00239 P30CA036727

Last trial update was posted on 2023-10-24

MeSH Interventions

Antibodies Antibodies, Monoclonal Antineoplastic Agents, Immunological Ascorbic Acid Bevacizumab Endothelial Growth Factors Immunoglobulin G Immunoglobulins Vitamins

MeSH Conditions

Glioblastoma Glioma

Other Conditions


Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID